1

FISA DE VERIFICARE A INDEPLINIRII STANDARDELOR MINIME NATIONALE in conformitate cu grila de evaluare a comisiei CNATDCU

MONITORUL OFICIAL AL ROMÂNIEI, PARTEA I, Nr. 890 bis/27.XII.2012

Anexa nr. 20 - COMISIA MEDICINĂ

STANDARDE MINIMALE NECESARE ŞI OBLIGATORII PENTRU CONFERIREA TITLURILOR DIDACTICE DIN

ÎNVĂŢĂMÂNTUL SUPERIOR ŞI A GRADELOR PROFESIONALE DE CERCETARE – DEZVOLTARE

Nr

crt Activitatea Tipul activității

Categorii si

restrictii Subcategorii

Indiatori

Kpi

0 1 2 3 4 5

1 Didactică

şi profe-

sională

1.1. cărți și

capitol în cărți

de specialitate

(cu ISBN)

– autor /

coautor

Criterii obligatorii:

1 capitol in tratat internațional = 1 carte națională;

1 carte internațional = 3 cărți naționale

Conferențiar – 1 carte de specialitate sau cel puțin 3 capitole într-un tratat

Profesor – 2 cărți (din care una ca prim autor sau autor unic) sau 6 capitole în tratate, de la ultima promovare

Îndeplinire: National

Carti ca autor

1. Victoria Burtea – Manual de semiologie psihiatrică, Casa de Editură

Venus, Iaşi, 2003.

2. Victoria Burtea – Manual de psihiatrie clinică, Casa de Editură Venus,

Iaşi, 2003

3. Victoria Burtea – Schizofrenia: repere clinico-terapeutice, Editura

Universităţii „Transilvania”, Braşov, 2004

4. Victoria Burtea – Breviar de psihopatologie. Editura Universităţii

„Transilvania”, Braşov, 2014

2

5. Victoria Burtea, Petru Ifteni – Psihopatologie – Cazuri clinice, Editura

Universităţii „Transilvania”, Braşov,

Criteriu indeplinit

1.2. cărți și

capitole în cărți

de specialitate

(cu ISBN) -

coordonator

Îndeplinire: internaționale

naționale

2 Cercetare 2.1. articole in

extenso in

reviste cotate

ISI Thomson

Reuters

Criterii obligatorii:

articole in reviste cu factor de impact, in calitate de autor principal, de la ultima promovare

Profesor – minim 6 articole

Conferențiar – minim 3 articole

Îndeplinire:

1. Moga M , Burtea V, Ifteni P, Socioeconomic status and psychological factors

involved in suicide, Revista de Cercetare si Interventie Sociala, 2014, vol. 45, pp.

230- 239

2. Szalontai A, Burtea V, Ifteni P. Blood Alcohol Concentration in Suicide: A

10 years Study, Revista de Cercetare si Interventie Sociala, 2014, vol. 46, pp. 144-

151

3. Szalontai A, Burtea V, Ifteni P. Predictors of Institutionalization in Dementia,

Revista de Cercetare si Interventie Sociala, 2015, vol. 49, pp. 249-257

4. Moga MA, Irimie M, Oanta A, Pascu A, Burtea V. Type-specific prevalence of

human papillomavirus by cervical cytology among women in Brasov, Romania.

Asian Pacific Journal of Cancer Prevention. 2014. Vol./is 15/16 (6887-92).

5. Ifteni P., Burtea V., Szalontay A.S., Moga M.A. Ethics of Treatment in Early

Psychosis, Revista Romana de Bioetica, in press

3

6. Moga MA, Arvatescu CA, Pratilas GC, Bigiu NF, Dinas K , Burtea V. The Role

of GaslessLaparoscopy in Differential Diagnosis of Acute Abdomen. Hippokratia,

in press, 2015.

Criteriu indeplinit

2.2. articole in

extenso in

reviste si

volumele unor

manifestări

științifice

indexate ISI

sau in alte BDI

Criterii obligatorii:

Profesor – minim 25 articole, din care 5 de la ultima promovare

Conferențiar – minim 15 articole din care 3 de la ultima promovare

1 articol ISI cu I.F. < 1 = 3 articole in reviste indexate BDI dar nu si invers

1 articol ISI cu I.F. ≥ 1 = 5 articole in reviste indexate BDI dar nu si invers (I.F. = impact factor)

Îndeplinire: Articole ISI cu I.F ≥ 1

1. Hans Rittmannsberger, Norman Sartorius, Victoria Burtea, Nora Căpraru, Pavel

Cernak, Mojka Dernovcek, Ionescu Dobrin, Rosa Frater, Jozef Hasto, Mieta

Hategan, Manfred Haushofer, J. Kafka, Siegfried Kasper, Rodica Macrea, Ludvik

Nabelek, Peter Nawka, Vladimir Nowotny, Thomas Platz, Adela Pojar, Christoph

Silberbauer, Matyas Trixler, Johannes Wancata, Elmar Windhager, Hans-Georg

Zapatoczky, Robert Zochling - Changing aspects of psychiatric inpatient treatment.

A census investigation in five European countries,European Psychiatry, 19 (2004),

483-488

2. Steven G. Potkin, Georges M. Gharabawi, Andrew J. Greenspan, Rammy

Mahmoud, Colette Kosik-Gonzalez, Marcia F.T. Rupnow, Cynthia A. Bossie,

Michael Davidson, Victoria Burtea, Young Zhu, Jintendra K. Tivedi – A double

blind comparison of risperidone, quetiapine and placebo in patients with

schizophrenia experiencing an acute exacerbation requiring hospitalisation,

Schizophrenia Research 85 (2006), 254-265

3. Ifteni P, Correll CU, Nielsen J, Burtea V, Kane JM, Manu P. Rapid clozapine

titration in treatment-refractory bipolar disorder, J Affect Disord. 2014

4

Sep;166:168-72. doi:10.1016/j.jad.2014.04.020. Epub 2014 May 20.

4. Ifteni P, Correll CU, Burtea V, Kane JM, Manu P., Sudden unexpected

death in schizophrenia: autopsy findings in psychiatric inpatients, Schizophr Res.

2014 May;155(1-3):72-6. doi: 10.1016/j.schres.2014.03.011. Epub 2014 Apr 4.

5. Ifteni P, Nielsen J, Burtea V, Correll CU, Kane JM, Manu P, Effectiveness and

safety of rapid clozapine titration in schizophrenia, Acta Psychiatr Scand. 2014

Jul;130(1):25-9. doi:10.1111/acps.12241. Epub 2013 Dec 20.

6. Ifteni P, Moga MA, Burtea V, Correll CU. Schizophrenia relapse after stopping

olanzapine treatment during pregnancy: a case report. Therapeutics and clinical risk

management. 2014. 10:901-904

Articole in reviste indexate BDI

1. Burtea V., Ifteni P., Sumedrea A.G., Mosoiu C. The treatment option in the

current practice in acute exacerbation of schizophrenia in Brasov county. Romanian

Journal of psychopharmacology, 2011, vol11, Issue 2, pp: 99-108

http://www.psychopharma.eu/revi ste/Vol.%2011,%20Nr.%202.pdf

2. Ifteni P., Burtea V., Teodorescu A. Patterns of antipsychotic use model in

treatment of Bipolar I disorder – a 12 months observational study. Bulletin Of The

Transilvania University, vol 4(53), Series VI, NO.1/2011, pp:73-76

http://webbut.unitbv.ro/bu2011/Series%20VI/BULETIN%20VI%20PDF/13_IFTE

NI.pdf

3. Burtea V., Ifteni P., Constantin D. Consideration about treatment noncompliance

in schizophrenia and hospital addressability. Bulletin Of The Transilvania

University, vol 4(53), Series VI, NO.1/2011, pp:67-72

http://webbut.unitbv.ro/bu2011/series%20vi/buletin%20vi%20pdf/12_burtea_mare.

pdf

4. Burtea V., Ifteni P., Teodorescu A., Rogozea L. Clozapine in treatment of

schizophrenia. Bulletin Of The Transilvania University, vol 4(53), Series VI,

NO.2/2011,pp:111-116

http://webbut.unitbv.ro/BU2011/Series%20VI/BULETIN%20VI/16 BURTEA.pdf

5

5. Ifteni P., Burtea V., Ifteni G., Taran L., Rogozea L. Admission to the psychiatric

emergency services of patients with alcohol- related mental disorder. Bulletin Of

The Transilvania University, vol 4(53), Series VI, NO.2/2011, pp:117-122

http://webbut.unitbv.ro/BU2011/S eries%20VI/BULETIN%20VI/17 _IFTENI.pdf

6. Burtea V., Rogozea L., Ifteni P. Ethical Significance of Lack of Insight and

Informed Consent in Schizophrenia. Bulletin Of The Transilvania University, vol

5(54), Series VI, NO.1/2012, pp:43-48

http://webbut.unitbv.ro/BU2012/Series%20VI/BULETIN%20VI%20PDF/07_BUR

TEA_ROGOZEA.pdf

7. Burtea V., Ifteni P., Pascu A. The QTC Interval in Patients Treated with

Antipsychotics. Archives of the Balkan Medical Union, vol 48, nr. 4, dec 2013, pp

404-405 http://umbalk.org/reviews/2013/u mb%204'2013%20rezumate.pdf

8. Burtea V., Ifteni P., Vârgă O., Teodorescu A. Analiza Fluentei Verbale in

Episodul Acut de Schizofrenie, Jurnalul Medical Brasovean nr.1- 2013, pp 54-58

http://webbut.unitbv.ro/jmb/JMB%202013%20nr%201/02_05_original%20burtea.p

df

9. Ifteni P., Burtea V., Teodorescu A. Caracteristicile socio- demografice ale

pacientilor cu schizofrenie si sindrom metabolic, Jurnalul Medical Brasovean nr.2-

2013, pp 50-55

http://webbut.unitbv.ro/jmb/JMB%202013%20nr%202/02_08_orig

inal%20ifteni.pdf

10.Dima L.,Ifteni, Pascu A, Burtea V., Moga M. New Theory in Schizophrenia and

Implications in Antipsychotics Development. Archives of the Balkan Medical

Union, 2014, vol. 49, no. 2, pp.

http://umbalk.org/reviews/2014/2 014%20-%202.pdf

11. Burtea V.,Ifteni P., Pascu A. Gender Differences in Major Depression with

Metabolic Syndrome. Archives of the Balkan Medical Union, 2014, vol. 49, no. 1,

pp. 40‐42

http://umbalk.org/reviews/2014/2 014%20-%201.pdf

6

12. Moga M.A., Arvătescu C.,Burtea V., Spulber R.,Pascu A.,Țînț D. Review of

Statins Treatment in Polycystic Ovary Syndrome. Archives of the Balkan Medical

Union in press

13. Moga M.A., Arvătescu C., Anastasiu C.,Ungureanu D.,Mironescu A., Burtea

V. Fetal Hydrothorax – a Case Report. Archives of the Balkan Medical Union in

press

14. Moga M., Bigiu N., Pascu A., Badea M., Burtea V. Polychlorinated Biphenils

Impact on Pregnancy. Archives of the Balkan Medical Union, 2014, vol. 49, no. 1,

pp. 61-65

http://umbalk.org/reviews/2014/u mb%201'2014%20rezumate.pdf

Criteriu indeplinit 2.3 granturi

/proiecte

castigate prin

competitie

(director

/responsabil

proiect)

Criterii obligatorii: Profesor – minim 3 granturi/proiecte, din care 1 ca director de proiect

Conferentiar – minim 2 granturi/proiecte,din care 1 ca responsabil de proiect

Îndeplinire: Granturi / proiecte - membru

1. Bioanalytical Methods – Linking Environmental Protection and Public Health –

51388 – IC – 1- 2003-RO- ERASMUS-DISSUC-2, MEMBRU

2. Leonardo da Vinci – Community Vocational Training Action Programme – PMH

– PROMENTALHEALTH, Exchange of Competencies for Trainers on Mental

Health Promotion – RO/2006/971125/Ex, MEMBRU

3.Matra - Reinforcement of the Integrated System of Extramural Mental Health

Care Services in Three Counties in Romania Asociatia de Servicii Sociale SCUT-

coordonator local, Spitalul de Psihiatrie si Neurlogie Isi II membru - partener,

Universitatea Transilvania – partener, MEMBRU

Granturi / proiecte - Director / responsabil de proiect

1. Proiect naţional de cercetare stiintifica cu terti si Universitatea “Transilvania” nr

23/16.09.2008 cu titlul „Impactul simptomatologiei anxios-depresive asupra

densitatii minerale a osului la subiectii sub 45 de ani”, in valoare de 10150 RON,

DIRECTOR

2. Proiect internaţional de cercetare stiintifica intre BIOLINERX (Israel) si

7

Universitatea „Transilvania” Brasov cu nr 155/8.01.2009, in valoare de 10500 Euro,

Sursa de finantare: BIOLINERX (Israel ), DIRECTOR

3.Proiect internaţional de cercetare stiintifica intre Stanley Medical Research

Institute si Universitatea „Transilvania” Brasov cu nr 6937/28.05.2009, in valoare

de 10200 EuroSursa de finantare: Stanley Medical Research Institute (US),

DIRECTOR

4. Proiect naţional de cercetare stiintifica cu terti si Universitatea “Transilvania” nr

6658/22.05.2009 cu titlul „Modelul de tratament al schizofreniei in judeţul Braşov”,

in valoare de 10100 RON Sursa de finantare: Sanofi, DIRECTOR

Criteriu indeplinit

2.4 articole

publicate in

rezumat in

reviste si

volumele unor

manifestari

stiintifice cu

ISBN sau ISSN

Criterii obligatorii: Profesor – minim 8 articole din care 3 in ultimii 5 ani

Conferentiar – minim 3 articole din care 1 in ultimii 5 ani

Îndeplinire: 1. Burtea V, Mosoiu C., Auditory Scene Analysis and Perceptual Streaming in

Patient with Schizophrenia. The Journal of the European College of

Neuropsychopharmacology, 2005, vol 15 ( Supp. 3 ), pp S525. Abstracts of the 18

ECNP Congress Amsterdam, Netherland, october 22-26,2005

2. Burtea V, Sangeorzan L, Rogozea L, Mosoiu C, Nedelcu A, Popescu M, Iliescu

M, Munteanu RI, Fraustosolis J, Sireteanu T, Cârstea I, Bagnar G. An Empirical

Investigation of Perceived Violence in Communication in Six Different University

Settings in Romania, WSEAS nov 07-09, Bucureşti, România, 2008; pp: 512-517;

proceeding indexat ISI.

http://www.wseas.us/e- library/conferences/2008/buchare st2/macmese/macmese-

S10.pdf

3. Rogozea L, Cristea L, Baritz M,Burtea V. Telemedicine and ethical dilemmas.

Proceedings Of The 8th Wseas International Conference On Artificial Intelligence,

Knowledge Engineering And Data Bases.Book Series: Artificial Intelligence Series

WSEAS 2009, 41-45

http://www.wseas.us/e- library/conferences/2009/cambridge/AIKED/AIKED03.pdf

8

4.Rogozea L, Miclaus R, Repanovici A, Burtea V., et al. Health promotion –

strategies and topics Educating the students from nursing and optometry

department. 9th WSEAS International Conference on Education and Educational

Technology. SELECTED TOPICS IN EDUCATION AND EDUCATIONAL

TECHNOLOGY 2010, 263-267

http://www.wseas.us/books/2010/Japan/EDU.pdf

5. Mosoiu C, Sumedrea A.G, Burtea V, Ifteni P. Fuzzy systems approach to

symptoms in schizophrenia. Proc. of the 11th WSEAS Int. Conf. On Neural

Networks, NN 10. Proceedings of the 11th WSEAS Int. Conf. On Evolutionary

Computing, EC '10, Proc. Of the 11th WSEAS Int. Conf. On Fuzzy Systems,

FS'10 2010, 268-272

http://www.wseas.us/e- library/conferences/2010/Iasi/NN ECFS/NNECFS-00.pdf

6. Ifteni P., Burtea V., Chirita V., Mosoiu C. The Influence of Metabolic

Syndrome in Major Depressive Disorder Outcome. WSEAS Athena, Greece,

September 28-30 2009; pp: 438- 440

7.Mosoiu C., Burtea V., Sumedrea A.G., Ifteni P. Syndrome Specification by

Factor Analysis in Schizophrenia. WSEAS Athena, Greece, September 28-30 2009;

pp: 511-515

8. Ifteni P., Burtea V., Mosoiu C. Prevention of Relapses in the Bipolar I Disorder:

a Comparative Study between Quetiapine Monotherapy vs. Quetiapine- Valproate

Combined Therapy. WSEAS Athena, Greece, September 28-30 2009; pp: 435- 437

9. Burtea VD., Burtea V., Mosoiu C., Sumedrea AG., Dimensions of Anxiety

Symptoms in Romanian Young Adult Subjects from Brasov County. WSEAS

Athena, Greece, September 28-30 2009, pp 507-510

http://www.wseas.us/elibrary/con ferences/2009/vouliagmeni/ACC

MM/ACCMM2-17.pdf

9

10. Burtea V.,Mosoiu C.,Vârciu M.,Leaşu F. The Overlap of Depression and

Anxiety Symptoms in a Community Sample of Romanian Young Adults.

Proceedings of 11th WSEAS International conference on Mathematical and

computational methods in science and engineering, September 2009, pp 503-506

http://www.wseas.us/elibrary/con ferences/2009/vouliagmeni/ACC

MM/ACCMM2-16.pdf

11. Dima L., Podasca C., Rogozea L.,Balescu A.,Burtea V. Hospital web pages – a

Brasov case study. Proceedings of 12th WSEAS International conference on

Mathematical and computational methods in science and engineering, November

2010, pp 331-335

http://www.wseas.us/elibrary/conferences/2010/Faro/MACMESE/ MACMESE-

55.pdf

12. Ifteni P., Burtea V., Mosoiu C., Rogozea L. Ethic aspects medical information

through computers and internet.WSEAS,2011, pp:159- 162

http://www.wseas.us/e- library/conferences/2011/Iasi/ED UTE/EDUTE-28.pdf

Criteriu indeplinit

2.5. proiecte

educationale si

de formare

continua

Îndeplinire:

3 Recunoa-

şterea şi

impactul

activităţii

Premii Îndeplinire:

Citări in reviste

ISI şi BDI - 0,05

pct/citare

Îndeplinire:

3.3 Prezentări

invitate în

plenul unor

manifestări

ştiinţifice

naţionale şi

internaţionale

Îndeplinire:

10

3.4.profesor

invitat (exclusive

ERASMUS)

3.5. membru în

colectivele de

redacţie sau co-

mitete ştiinţi-

fice, organizator

de manifestări

ştiinţifice

Îndeplinire: 1. Comitet de redactie Romanian journal of Psychopharmacology 2003

2. Comitet de redactie Jurnalul Medical Brasovean

3. Comitet Stiintific National - Simpozionul National de Psihiatrie. Personalitate normala

si patologice. Tulburari anxioase si de dispozitie. 2001

4. Comitet Stiintific International Conferinta Internationala " Enviornmental

Pollution and It's Impact on Public Health" 2008

5. Comitetul Stiintific Conferinta Nationala de Psihiatrie 2009

6. Comitet Stiintific Onorific Prima Consfatuire Nationala de Istorie a Psihiatriei

Romanesti 2009

7. Comitet Stiintific National Conference of Biological Psyhchiatry and

Psychopharmacology 2010

8. Comitet Stiintific International - International Academic Autumn School " Impact of

enviormental pollution on public health " 2011

9.Comitet Stiintific Al IV-Lea Congres National de Psihiatrie 2011

3.6 recenzor

pentru reviste şi

manifestări

ştiinţifice naţio-

nale şi interna-

ţionale indexate

ISI/BDI

Îndeplinire:

3.7 membru

comisii de

doctorat

(exclusiv

preşedinte) şi

abilitare

1. Universitatea de Medicina si Farmacie Craiova, Ordinul Rectorului Universitatii

de Medicina si Farmacie Craiova nr. 8/B din 29.06.2010 - membru referent in

comisie de sustinere a tezei de doctorat elaborata de Dna Raducanu M. Emilia

pentru obtinerea titlului stiintific de Doctor in Medicina.

3.8 experienţa

de management

în cercetare

şi/sau

Îndeplinire: I. I. Investigator principal in trialuri internationale. 1.TRIAL 100 – Stamina. An international, multicentre, double- blind,

randomised, placebo- controlled study of the safety and efficacy of Seroquel

11

învăţământ (Quetiapine fumarate) as add-on therapy with lithium and divalproex in the

treatment of acute mania. Investigator meeting - Monte Carlo, 23-25.07.2001

2. TRIAL 105 – Stamp 2. An international, multicentre, double- blind,

randomised, placebo- controlled study of the safety and efficacy of seroquel

(quetiapine fumarate) and lithium as monotherapy in the treatment of acute

mania. Investigator meeting - Monte Carlo, 23-25.07.2001

3. TRIAL RIS-SCP 402. A Randomised, Double-blind Study to Evaluate the

Efficacy and Safety of Risperidone vs. Quetiapine vs. Placebo in Subjects with

an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder.

Investigator meeting – Salonic, Grecia, septembrie 2003

4. EUFEST. The European First Episode Schizophrenia Trial – comparison of

outcome in first episode schizophrenia with different low dose antipsychotic

drug regimens. Investigator meeting – Bucureşti, noiembrie 2003; Paris,

20.06.2004

5. TRIAL 10124. A double blind, randomised study of long-term bifeprunox

efficacy, safety and tolerability in patients with chronic schizophrenia

6. TRIAL N3D/FOR-OCA-05. Multicentre,double-blind, placebo controlled,

rising dose, parallel group study of the efficacy and tolerability of ocaperidone

in schizophrenic patients. Investigator meeting – Colmar, Franţa, februarie 2004

7. TRIAL N3D/FOR-OCA-08. Multicentre, double-blind, placebo controlled,

rising dose, parallel group study of the efficacy and tolerability of ocaperidone

in schizophrenic patients – extension of N3D/FOR-OCA-05. Investigator

meeting – Colmar, Franţa, februarie 2004

8. STAGE. A 24-week, International, Multi-centre, Open- label, Flexibile-dose,

Randomised, Parallel-Group, Phase IV Study to Compare the Effect on Glucose

Metabolism of Quetiapine, Olanzapine and Risperidone in the Treatment of

Patients with Schizophrenia. Investigator meeting – Dresda, februarie 2004

9. REASSURE I. A 6-week, International, Multicenter, Double-blind, Double-

dummy, Randomized Comparison of the Efficacy and Safety of Sustained-

Release Formulation Quetiapina Fumarate (SEROQUEL) and Placebo in the

Treatment of Acutely Ill Patients with Schizophrenia. Investigator meeting –

Frankfurt, Germania, mai 2004

12

10. TRIAL RO76477-SCH-1010. A Double Blind, Placebo- Controlled,

Randomised Study Evaluating the effect of ER OROS Paliperidone Compared

to Placebo on Sleep in Subjects with Schizophrenia

11. TRIAL D1447C00144. Multicenter, randomised, Parallel- group, Double-

Blind, Placebo- controlled Phase III Study of the Efficacy and Safety of

Quetiapine Fumarate and Lithium as Monotherapy for up to 104 weeks

Maintenance Treatment of Bipolar I Disorder in Adult Patients, 2004

12. TRIAL TRIAL 041023. A Multicenter, randomised, Double- Blind, fixed-

dose, 6 weeks trial of the efficacy and safety of asenapine compared with

placebo using a haloperidol positive control in subjects with an acute

exacerbation of schizophrenia, phase IIIa, 2005-2006

13. TRIAL 041513. A double-blind, flexible dose, positive-controlled,

multicenter, long term extension of a randomized trial for subjects who have

completed the 6 weeks short term trial 041023; phase IIIa, 2006

14. TRIAL BL – 1020 Phase IIa, 2007-2008. An open-label, multicenter, six-

weeks, sequential cohort study designed to determine the safety and tolerability

of two dose ranges of BL-1020 in hospitalized subjects with chronic

schizoprenia or schizoaffective disorder

15. TRIAL BL – 1020 Phase IIb, 2008-2009. A six week, randomized,double-

blind, placebo- controlled, parallel group, multi-center, phase IIb study to

determine the eficacy, safety and tolerability of low and high non-overlapping

dose ranges of BL-1020 compared to placebo and Risperidone in patients with

acute exacerbations of schizophrenia

16. TRIAL ALL-S-01 Phase III, 2009-2010. Allopurinol in schizophrenia: a

randomized trial administering Allopurinol vs placebo as add-on to

antipsychotics in patients with schizophrenia or schizoaffective disorder

17. TRIAL CL3- 20098-083 Early effect of agomelatine on general interest in

outpatients with Major Depressive Disorder.

18. TRIAL P05691 2011 A Phase 3b, Multicenter,Double-Blind, Fixed-Dose,

Parallel Group, Three week Placebo Controlled Trial Evaluating the Safety and

Efficacy of Asenapine in Subjects with Bipolar 1 Disorder, Experiencing an

Acute Manic or Mixed Episode.

13

19. TRIAL P05692 2012-2014 A Multicenter,Double-Blind, Fixed- Dose,

Long Term Extension Trial, of the Safety of Asenapine in Subjects with

Bipolar 1 Disorder who Completed Protocol P05691

20. TRIAL P05688 2012-2014 A Multicenter, Randomized, Double-Blind,

Fixed-Dose,6 Week Trial of the Efficacy and Safety of Asenapine Compared

with Placebo Using Olanzapine as an Active Control in Subjects with an Acute

Exacerbation of Schizophrenia.

II. Sef Catedra de Specialitati Medicale 2008-2012

III. Director de Departament DFPC din anul 2013

3.9. participare

efectivă

manifestări

ştiinţific

Îndeplinire: